These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7594878)

  • 1. An example of the effects of drug resistance on the optimal schedule for a single drug in cancer chemotherapy.
    Murray JM
    IMA J Math Appl Med Biol; 1995; 12(1):55-69. PubMed ID: 7594878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy.
    Murray JM
    IMA J Math Appl Med Biol; 1997 Dec; 14(4):283-303. PubMed ID: 9415996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1994; 11(1):45-59. PubMed ID: 8057040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle.
    Murray JM
    Math Biosci; 1994 Oct; 123(2):183-213. PubMed ID: 7827419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General applications of optimal control theory in cancer chemotherapy.
    Swan GW
    IMA J Math Appl Med Biol; 1988; 5(4):303-16. PubMed ID: 3241099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal control applications in the chemotherapy of multiple myeloma.
    Swan GW
    IMA J Math Appl Med Biol; 1985; 2(3):139-60. PubMed ID: 3870983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of heterogeneity on optimal regimens in cancer chemotherapy.
    Murray JM; Coldman AJ
    Math Biosci; 2003 Sep; 185(1):73-87. PubMed ID: 12900142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical model of cancer chemotherapy with an optimal selection of parameters.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1990 May; 99(2):205-30. PubMed ID: 2134520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the MTD paradigm and optimal control for multi-drug cancer chemotherapy.
    Ledzewicz U; Schättler H; Gahrooi MR; Dehkordi SM
    Math Biosci Eng; 2013 Jun; 10(3):803-19. PubMed ID: 24063059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential innovations in scheduling of cancer chemotherapy.
    Norton L; Day R
    Important Adv Oncol; 1991; ():57-72. PubMed ID: 1869282
    [No Abstract]   [Full Text] [Related]  

  • 11. A mathematical model of the development of drug resistance to cancer chemotherapy.
    Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some drug-resistant models for cancer chemotherapy. Part 1: Cycle-nonspecific drugs.
    Usher JR; Henderson D
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):99-126. PubMed ID: 8671582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach.
    Ledzewicz U; Wang S; Schattler H; Andre N; Heng MA; Pasquier E
    Math Biosci Eng; 2017 Feb; 14(1):217-235. PubMed ID: 27879129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer chemotherapy.
    Secchi GC
    Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
    Hofsli E
    Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling chemotherapy resistance in palliation and failed cure.
    Monro HC; Gaffney EA
    J Theor Biol; 2009 Mar; 257(2):292-302. PubMed ID: 19135065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronomic chemotherapy: Back to the future!
    André N; Padovani L; Verschuur A
    Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The worst drug rule revisited: mathematical modeling of cyclic cancer treatments.
    Katouli AA; Komarova NL
    Bull Math Biol; 2011 Mar; 73(3):549-84. PubMed ID: 20396972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
    Boldrini JL; Costa MI
    IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal control for a cancer chemotherapy problem with general growth and loss functions.
    Murray JM
    Math Biosci; 1990 Mar; 98(2):273-87. PubMed ID: 2134507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.